Orexin-1 receptor (OX1R) neurons are neurons that express the orexin-1 receptor, a G protein-coupled receptor that binds orexin-A and orexin-B neuropeptides. These neurons are widely distributed throughout the brain and play critical roles in wakefulness, arousal, feeding behavior, reward processing, and energy homeostasis[1][2]. The orexin system was discovered in 1998 and has since been recognized as essential for maintaining normal sleep-wake states.
| Property |
Value |
| Category |
Neuropeptide receptor neurons |
| Location |
Hypothalamus, limbic system, brainstem |
| Neurotransmitter |
Glutamate (primarily) |
| Receptor |
Orexin-1 Receptor (HCRTR1) |
The OX1R is encoded by the HCRTR1 gene:
- Gene: HCRTR1 (Hypocretin/Orexin Receptor 1)
- Protein: 425 amino acids, 7 transmembrane domains
- G protein coupling: Gq/11 (primarily)
- Signal transduction: ↑ IP3, ↑ intracellular calcium
- Ligands: Orexin-A > Orexin-B (10-fold selectivity)
Two orexin peptides derived from the same precursor:
- Orexin-A (hypocretin-1): 33 amino acids, disulfide bonds
- Orexin-B (hypocretin-2): 28 amino acids, linear
OX1R expression is enriched in:
- Hypothalamus: Arcuate nucleus, lateral hypothalamus
- Limbic system: Hippocampus, amygdala
- Brainstem: Locus coeruleus, dorsal raphe
- Cortex: Layer-specific expression
- Thalamus: Paraventricular nucleus
¶ Wakefulness and Arousal
OX1R neurons are crucial for maintaining wakefulness[^3]:
- Sleep-wake regulation: Orexin promotes wakefulness, inhibits sleep
- Narcolepsy: Loss of orexin neurons causes narcolepsy with cataplexy
- Arousal threshold: OX1R activation increases behavioral arousal
The orexin system integrates metabolic state with behavior[^4]:
- Food intake: Orexin stimulates feeding, especially of high-calorie foods
- Energy homeostasis: Responds to glucose, leptin, ghrelin
- Feeding motivation: OX1R in nucleus accumbens drives food-seeking
¶ Reward and Motivation
OX1R modulates mesolimbic dopamine pathways[^5]:
- VTA neurons: Orexin projects to ventral tegmental area
- Drug reward: OX1R blockade reduces nicotine, cocaine reward
- Motivation: OX1R activity influences motivated behaviors
- Cardiovascular: Modulates blood pressure and heart rate
- Respiratory: Controls breathing patterns
- Thermoregulation: Affects body temperature regulation
| Property |
Value |
| Resting membrane potential |
-50 to -60 mV |
| Action potential |
~1 ms, broad |
| Firing pattern |
Irregular tonic, burst |
| Depolarizing current |
Depolarizes in response to orexin |
- Orexin response: Prolonged depolarization with increased firing
- Synaptic inputs: Receives from prefrontal cortex, amygdala
- Output targets: Wide projections to wake-promoting nuclei
OX1R is central to narcolepsy pathophysiology[^6]:
- Cause: Autoimmune destruction of orexin neurons
- Therapeutic: OX1R agonists being investigated
- Diagnosis: Low CSF orexin-A is diagnostic marker
- Orexin loss: Reduced orexin neurons in PD
- Sleep disorders: Contributes to REM sleep behavior disorder
- Therapeutic potential: OX1R modulators may improve wakefulness
- Nicotine: OX1R blockade reduces nicotine seeking
- Alcohol: OX1R modulates alcohol consumption
- Cocaine: OX1R affects cocaine reward and relapse
¶ Depression and Anxiety
- Mood regulation: OX1R dysfunction linked to depression
- Anxiety: OX1R activation produces anxiogenic effects
- Therapeutic potential: OX1R antagonists in development
- Dual receptors: OX1R and OX2R have distinct but overlapping functions[^7].
- Circuit-specific: OX1R effects depend on brain region.
- Sleep architecture: OX1R antagonists promote sleep, useful for insomnia.
- Suvorexant: Dual OX1R/OX2R antagonist approved for insomnia
- Selective OX1R antagonists: In development for addiction, depression
- OX1R agonists: Being investigated for narcolepsy
- Sakurai et al. Orexin receptors (2014)
- de Lecea & Sutcliffe. Hypocretins (2005)
- Jones. Orexin and wakefulness (2005)
- Wynne & Sarkar. Orexin and feeding (2003)
- Mahler et al. Orexin and reward (2012)
- Nishino et al. Narcolepsy and orexin (2000)
- Mieda & Sakurai. Orexin receptor subtypes (2011)